Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 15;5(3):393-8.
doi: 10.4239/wjd.v5.i3.393.

Diabetic nephropathy and inflammation

Affiliations
Review

Diabetic nephropathy and inflammation

Montserrat B Duran-Salgado et al. World J Diabetes. .

Abstract

Diabetic nephropathy (DN) is the leading cause of end-stage renal failure worldwide. Besides, diabetic nephropathy is associated with cardiovascular disease, and increases mortality of diabetic patients. Several factors are involved in the pathophysiology of DN, including metabolic and hemodynamic alterations, oxidative stress, and activation of the renin-angiotensin system. In recent years, new pathways involved in the development and progression of diabetic kidney disease have been elucidated; accumulated data have emphasized the critical role of inflammation in the pathogenesis of diabetic nephropathy. Expression of cell adhesion molecules, growth factors, chemokines and pro-inflammatory cytokines are increased in the renal tissues of diabetic patients, and serum and urinary levels of cytokines and cell adhesion molecules, correlated with albuminuria. In this paper we review the role of inflammation in the development of diabetic nephropathy, discussing some of the major inflammatory cytokines involved in the pathogenesis of diabetic nephropathy, including the role of adipokines, and take part in other mediators of inflammation, as adhesion molecules.

Keywords: Adhesion molecules; Albuminuria; Cytokines; Diabetic Nephropathy; Inflammation.

PubMed Disclaimer

References

    1. Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433–442. - PubMed
    1. Gaballa M, Farag MK. Predictors of Diabetic Nephropathy. Eur J Med. 2013;8:287–296.
    1. Lopez-Parra V, Mallavia B, Egido J, Gomez-Guerrero C. Immunoinflammation in Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Options. In: Chan JSD. Diabetic Nephropathy. InTech, Chapters; 2012. pp. 127–146.
    1. Sanchez AP, Sharma K. Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med. 2009;11:e13. - PubMed
    1. Navarro-González JF, Jarque A, Muros M, Mora C, García J. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev. 2009;20:165–173. - PubMed